Ctrl K
OFF-2026-0001Novartis Pharma AGTKBE · EUR · v1
Offer Ongoing
Net contract value
EUR 6,820
List EUR 6,820
Blended margin
21.7%
0%3045100%
Total effort
7 days
2 activities · 2 profiles
Cost & gross profit
EUR 1.5k
cost EUR 5,341 · GP EUR 1,479
Avg blended rate
EUR 974/d
across 2 profiles
Readiness & gates
Pricing
100%
Narrative
20%
Appr
TypeCountryCurrency EURFX rateDiscount %Rebate %
Presets
Days allocated per profile · click any cell to edit
2 profiles below the 30% margin floor — PC, EC. Review rate or staffing mix before sending.
Activity / Sub-activity
PC
🇧🇪
1,045 /day
cost €90813.2 %
EC
🇧🇪
946 /day
cost €70525.5 %
Total
A01
3,036
17.0% margin
A02
3,784
25.5% margin
Profile totals
2 d
2,090
5 d
4,730
Net total
6,820

Scenarios — sensitivity

Revenue
€6,820
Cost
€5,341
GP €
€1,479
GP %
21.7%
ScenarioRevenueCostGP €GP %
Base€6,820€5,341€1,47921.7%

Scenarios are a what-if view (not saved). Rebate affects GP-after-rebate, not Revenue.

Allocation — estimated resources

ProfileEffort (d)Estimated headcount
PC · BE2
0.01
EC · BE5
0.02

Headcount = effort days ÷ working days. Maps to PQE staffing (Jasper) later.

Approval gates0 pendingAll gates pass
GP %
21.7%
Approval neededSales Director
GP discount delta
Discount delta within tolerance
OKPQE Mgmt
Offer amount
EUR 6,820
OKPQE Mgmt
Subcontracting completeness
All subcontracting rows pass markup + verification
OKPQE VP
Offer validation0 blockingURS_OLM 1.17.2–1.17.6
All offer-integrity checks pass.